Molecular characterization of epithelioid sarcoma (ES) tumors derived from patients enrolled in a phase II study of tazemetostat (NCT02601950) Meeting Abstract
| Authors: | Daigle, S.; Stacchiotti, S.; Schöffski, P.; Villalobos, V.; Cote, G.; Chugh, R.; Chen, T. W. W.; Jahan, T.; Loggers, E. T.; Italiano, A.; Gupta, A.; Agulnik, M.; Attia, S.; Jones, R. L.; van Tine, B. A.; Demetri, G. D. D.; Clawson, A.; Roche, M.; Blakemore, S.; Gounder, M. |
| Abstract Title: | Molecular characterization of epithelioid sarcoma (ES) tumors derived from patients enrolled in a phase II study of tazemetostat (NCT02601950) |
| Meeting Title: | 43rd ESMO Congress (ESMO 2018) |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2018 Oct 19-23 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-10-01 |
| Start Page: | mdy304 |
| Language: | English |
| ACCESSION: | WOS:000459277304256 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy304 |
| Notes: | Meeting Abstract: 1892O -- Appears on page viii670 of the abstract book -- Source: Wos |
